immunological
Lilly and Hanmi enter immunological therapy pact
March 20, 2015Research and Development, Sales and Marketing HM71224, Korea, Sjögren, hanmi, immunological, lilly
Eli Lilly and Korean-based pharma firm Hanmi have entered a collaboration agreement to develop and commercialise an immunological therapy. The …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
